Inactive Instrument
Lipidor AB Stock Deutsche Boerse AG
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -50.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -50.34% | -59.44% | - | - | 92.63K | |
| -1.09% | +2.93% | +57.74% | +170.69% | 1,102B | |
| -0.58% | +4.55% | +70.45% | +66.48% | 643B | |
| -0.43% | +1.17% | +33.85% | +88.86% | 450B | |
| -1.35% | +1.86% | +29.96% | +26.26% | 336B | |
| -0.71% | +0.72% | +28.85% | +46.77% | 288B | |
| -1.31% | -0.26% | -28.18% | -39.13% | 222B | |
| -0.10% | +2.05% | +24.15% | +64.08% | 199B | |
| -0.94% | +7.74% | +22.20% | +79.30% | 169B | |
| +0.27% | +1.26% | -5.62% | -32.23% | 137B | |
| Average | -5.65% | +2.26% | +25.93% | +52.34% | 393.9B | |
| Weighted average by Cap. | -0.79% | +2.07% | +40.64% | +86.36% |
Employees
4
Sector
Pharmaceuticals
Choose MarketScreener 
